Century Therapeutics (IPSC) Current Leases (2022 - 2025)
Century Therapeutics (IPSC) posted quarterly Current Leases of $4.9 million for Q2 2025, up 33.61% year-over-year from $3.7 million in Q2 2024, and little changed quarter-over-quarter from $4.9 million in Q1 2025.
Century Therapeutics (IPSC) Current Leases (2022 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has reported Current Leases for 4 consecutive years, with $4.9 million the latest figure, recorded in Q2 2025.
- In Q2 2025, Current Leases rose 33.61% year-over-year to $4.9 million; the TTM figure through Jun 2025 stood at $4.9 million (up 33.61% YoY), while the FY2024 annual figure was $4.9 million, up 221.88% from the prior year.
- Current Leases was little changed at $4.9 million in Q2 2025 per IPSC's latest filing, from $4.9 million in the prior quarter.
- Across five years, Current Leases topped out at $4.9 million in Q2 2025 and bottomed at $475000.0 in Q4 2022.
- Historically, Current Leases has averaged $3.1 million across 4 years, with a median of $3.7 million in 2024.
- Annual changes were most pronounced in 2024 — Current Leases jumped 221.88% — and 2025, when it soared 33.61%.
- Century Therapeutics' Current Leases stood at $475000.0 in 2022, then surged by 218.53% to $1.5 million in 2023, then surged by 221.88% to $4.9 million in 2024, then climbed by 0.49% to $4.9 million in 2025.
- Business Quant data shows IPSC's Current Leases at $4.9 million in Q2 2025, $4.9 million in Q1 2025, and $4.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.89 Mn |
| Mar 31, 2025 | 4.88 Mn |
| Dec 31, 2024 | 4.87 Mn |
| Sep 30, 2024 | 3.76 Mn |
| Jun 30, 2024 | 3.66 Mn |
| Mar 31, 2024 | 2.22 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 2.04 Mn |
| Dec 31, 2022 | 475,000.00 |